DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Marre M, Shaw J, Brändle M. et al
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26
weeks produces greater improvements in glycaemic and weight control compared
with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1
SU).
Diabet Med 2009;
26: 268-278
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.